<SEC-DOCUMENT>0001140361-24-045343.txt : 20241106
<SEC-HEADER>0001140361-24-045343.hdr.sgml : 20241106
<ACCEPTANCE-DATETIME>20241106072246
ACCESSION NUMBER:		0001140361-24-045343
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241106
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241106
DATE AS OF CHANGE:		20241106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunocore Holdings plc
		CENTRAL INDEX KEY:			0001671927
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39992
		FILM NUMBER:		241429235

	BUSINESS ADDRESS:	
		STREET 1:		90 PARK DRIVE
		STREET 2:		MILTON PARK, ABINGDON
		CITY:			OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY
		BUSINESS PHONE:		01235 5430281

	MAIL ADDRESS:	
		STREET 1:		90 PARK DRIVE
		STREET 2:		MILTON PARK, ABINGDON
		CITY:			OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immunocore Ltd
		DATE OF NAME CHANGE:	20160412
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20038108_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:imcr="http://immunocore.com./20241106" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_1cd53765c7d64384a42eb28bf0b95bc9" contextRef="c20241106to20241106" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_adeda0fcc3224eabbbeb25f24d8e78ea" contextRef="c20241106to20241106">0001671927</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_9fe653d954de4755b60b19a3917feed9" contextRef="c20241106to20241106">00-0000000</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="imcr-20241106.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20241106to20241106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671927</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-06</xbrli:startDate><xbrli:endDate>2024-11-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">

  <div><span style="font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="font-size: 10pt;">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
  </div>

  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_ca45266cdc824e089d0d7fe7075c51ed" contextRef="c20241106to20241106">8-K</ix:nonNumeric></div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="font-size: 10pt;">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_d75e030939ee44c4a90b7a750089a473" contextRef="c20241106to20241106" format="ixt:date-monthname-day-year-en">November 6, 2024</ix:nonNumeric></div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="font-size: 10pt;">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
  </div>

  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_0ff371c6b84d4464886e7a127f5580c2" contextRef="c20241106to20241106">Immunocore Holdings plc</ix:nonNumeric><br/>
  </div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its Charter)</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="font-size: 10pt;">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_810a65b3a7d344f0a3119c25a252c800" contextRef="c20241106to20241106" format="ixt-sec:edgarprovcountryen">England and Wales</ix:nonNumeric><br/>
            </span></div>
        </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_5085908fe79442c1a669570a1a7f940a" contextRef="c20241106to20241106">001-39992</ix:nonNumeric><br/>
            </span></div>
        </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;"><span style="-sec-ix-hidden:Fact_9fe653d954de4755b60b19a3917feed9">Not Applicable</span><br/>
            </span></div>
        </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(State or other jurisdiction of incorporation)</div>
        </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
        </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(IRS Employer Identification No.)</div>
        </td>

  </tr>


</table>
  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_b65bc2914d3c4a9bb069e4af9c3e9f15" contextRef="c20241106to20241106">92 Park Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_bb5eaec8f04e4a4cb48ea8de2b3ccad4" contextRef="c20241106to20241106">Milton Park</ix:nonNumeric></div>
          <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine3" id="Fact_4b98402cd79e40c6b7006c60f084dbac" contextRef="c20241106to20241106">Abingdon</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_0f79bba9963d4a26849ef7da8f49812f" contextRef="c20241106to20241106">Oxfordshire</ix:nonNumeric>,</div>
          <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_e1097750da464755a29bd136ba8bbe89" contextRef="c20241106to20241106" format="ixt-sec:countrynameen">United Kingdom</ix:nonNumeric><br/>
          </div>
        </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_716d770ab6974ace8abf23e996a4f637" contextRef="c20241106to20241106">OX14 4RY</ix:nonNumeric><br/>
          </div>
        </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Address of principal executive offices)</div>
        </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Zip Code)</div>
        </td>

  </tr>


</table>
  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">+<ix:nonNumeric name="dei:CityAreaCode" id="Fact_212ec1f8f2dc427492d391baa1ee86a4" contextRef="c20241106to20241106">44</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a9b83eff89ac4a928db39f2aa853bc53" contextRef="c20241106to20241106">1235 438600</ix:nonNumeric></div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former name or former address, if changed since last report)</div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="font-size: 10pt;">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
    following provisions:</div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_8b0d0eaeaf8f43729fd1f893856137eb" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
        </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_fbe3715ec5df4b39966f53f803957aa0" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
        </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_518ccbbaf16d43d7a33bbe81eeb1b3b0" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
        </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_06a931cfab8c4e1bbc41452f85c4eaa1" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
        </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
        </td>

  </tr>


</table>
  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 62.09%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
        </td>

    <td style="width: 9.11%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
          <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
        </td>

    <td style="width: 28.55%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on which registered</div>
        </td>

  </tr>

  <tr>

    <td style="width: 62.09%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; text-align: center;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_7bcfd8b4b4854d32b6864532d70881c3" contextRef="c20241106to20241106">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share</ix:nonNumeric><br/>
          </div>
        </td>

    <td style="width: 9.11%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_21a85a61990a4d2fa6eb8308d1aee54c" contextRef="c20241106to20241106">IMCR</ix:nonNumeric><br/>
          </span></td>

    <td style="width: 28.55%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_57738f115e1e466fb007e1f768097b35" contextRef="c20241106to20241106" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>
            </div>
          </div>
        </td>

  </tr>

  <tr>

    <td style="width: 62.09%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Ordinary share, nominal value &#163;0.002 per share*</div>
        </td>

    <td style="width: 9.11%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">*</div>
        </td>

    <td style="width: 28.55%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">The Nasdaq Stock Market LLC</div>
        </td>

  </tr>


</table>
  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* <span style="font-family: 'Times New Roman'; font-style: italic;">Not for trading, but only in connection with the listing of the American Depositary
      Shares on The Nasdaq Stock Market LLC.</span></div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or
    Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_817885c40eeb40e0a6a33045bf337539" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
    revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="font-size: 10pt;">
    <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 81pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Results of Operations and Financial Condition.</div>
        </td>

  </tr>


</table>
  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; text-indent: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 6, 2024, Immunocore Holdings plc (the &#8220;Company&#8221;) issued a press release announcing its financial results for the third quarter
    ended September 30, 2024, as well as other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated by reference.</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; text-indent: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 2.02 of this Current Report on 8-K, including Exhibits 99.1 hereto, is being furnished and shall not be deemed
    &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company&#8217;s filings
    under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such
    filing.</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 81pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits</div>
        </td>

  </tr>


</table>
  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
        </td>

    <td style="width: 90%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
        </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><a href="ef20038108_ex99-1.htm">99.1</a></div>
        </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release dated November 6, 2024.</div>
        </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
        </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
        </td>

  </tr>


</table>
  <div style="font-size: 10pt;"><br/>
  </div>

  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

  </div>

  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
    undersigned hereunto duly authorized.</div>

  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
    </span></div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40.48%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td colspan="4" style="vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">IMMUNOCORE HOLDINGS PLC</div>
        </td>

  </tr>

  <tr>

    <td style="width: 40.48%; vertical-align: middle; font-size: 10pt;"><br/>
        </td>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;"><br/>
        </td>

    <td colspan="3" style="vertical-align: middle; font-size: 10pt;"><br/>
        </td>

  </tr>

  <tr>

    <td style="width: 40.48%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Dated: November 6, 2024</div>
        </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
        </td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Bahija Jallal, Ph.D.</div>
        </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40.48%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 8%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name:</div>
        </td>

    <td style="width: 42%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Bahija Jallal, Ph.D.</div>
        </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40.48%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;"><br/>
        </td>

    <td style="width: 8%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title:</div>
        </td>

    <td style="width: 42%; vertical-align: bottom; font-size: 10pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chief Executive Officer</div>
        </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

  </tr>


</table>
  <div style="font-size: 10pt;"><br/>
  </div>

  <div><span style="font-size: 10pt;"><br/>
  </span></div>

  <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20038108_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
    </font></div>
  <div> <font style="font-size: 10pt;"><br>
    </font></div>
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Immunocore reports third quarter financial results and provides a business update</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: center; margin-left: 3.3pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">KIMMTRAK<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (tebentafusp-tebn) net revenues of $80.2 million in 3Q 2024, 28% growth over 3Q 2023</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Phase 3 trials in cutaneous melanoma ongoing (PRISM-MEL-301 and TEBE-AM); and Phase 3 trial in adjuvant uveal melanoma (ATOM) to
      start randomizing in 4Q 2024</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Presented Phase 1 brenetafusp data in platinum-resistant ovarian cancer patients; ongoing signal detection in metastatic NSCLC
      will shift initial data release; focus now on earlier-line patients and combinations</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">3Q 2024 earnings per share (EPS) of $0.17 compared to 3Q 2023 EPS of $0.02</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US</font>, 06 November 2024)
      <u><font style="font-family: 'Times New Roman';">Immunocore Holdings plc (Nasdaq: IMCR) (&#8220;Immunocore&#8221; or the &#8220;Company&#8221;)</font></u>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to
      radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced its financial results for the third quarter ended September 30, 2024 and provided a business update.</div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are proud to report another strong quarter, marking two years of continuous growth for KIMMTRAK and another quarter of positive net income,&#8221; <font style="font-family: 'Times New Roman'; font-weight: bold;">said Bahija Jallal, Immunocore&#8217;s Chief Executive Officer</font>. &#8220;We are also making significant strides in advancing our broad pipeline &#8211; with brenetafusp in oncology, the HIV functional
        cure trial in infectious diseases, and in autoimmune diseases with tissue-targeted programs for type 1 diabetes and dermatologic diseases.&#8221;</div>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;KIMMTRAK&#8217;s 28% growth over Q3 last year is driven by higher demand in the United States and Germany and by expanded patient reach with 11 launches this year,&#8221; <font style="font-family: 'Times New Roman'; font-weight: bold;">said Ralph Torbay, Immunocore&#8217;s Chief Commercial Officer</font>. &#8220;We are excited about the potential to bring KIMMTRAK to more patients with melanoma through the Phase 3 TEBE-AM trial that
      is expected to complete enrollment in early 2026, and the Phase 3 ATOM trial that is planned to start randomization this quarter.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Third Quarter 2024 Highlights (including post-period)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">KIMMTRAK</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The Company&#8217;s lead product, KIMMTRAK, is approved in 38 countries and has been launched in 21 countries globally to date for HLA-A*02:01 positive
        patients with unresectable or metastatic uveal melanoma (mUM). KIMMTRAK continues to be the standard of care in most markets where it is launched. The Company sees three key growth areas for KIMMTRAK: continued expansion in mUM, the potential
        expansion into 2L+ advanced cutaneous melanoma and adjuvant uveal melanoma.</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Metastatic uveal melanoma</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4cf4af911027485faacc7ff5f1666ba4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">KIMMTRAK net product sales were $80.2 million and $225.9 million for the three and nine months ended September 30, 2024, respectively, representing increases of 28% and 32% respectively, compared
                to the prior year periods.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zf4b8e6d429c04abcadb625a10f44ca9b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Growth in the US and Germany was driven by increased demand based on continued community penetration and growing duration of treatment.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z346bd2c3ffc44eeba9c3d8416b7e5f38" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">New baseline blood gene expression signature data was presented at the European Society for Medical Oncology 2024 Meeting (ESMO 2024) confirming that T cell fitness in blood is an important
                parameter of clinical activity for KIMMTRAK in previously treated uveal melanoma.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">2L+ previously treated cutaneous melanoma</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z2fe6c0a4922843adb6f30db4c1685742" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Randomization continues in the registrational Phase 3 trial (TEBE-AM), which includes three arms &#8211; KIMMTRAK monotherapy, KIMMTRAK in combination with pembrolizumab, and control. The Company expects
                to complete randomization in the first half of 2026.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z29a25b64fd0445bdba0d472df8ebc5af" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The TEBE-AM Phase 3 trial in 2L+ cutaneous melanoma has a primary endpoint of overall survival.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Adjuvant uveal (or ocular) melanoma</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zd10d6e4f3f0c4258832543a5abdd6ebf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Randomization in the ATOM Phase 3 trial, led by the European Organisation for Research and Treatment of Cancer (EORTC), is on track to start in the fourth quarter of 2024.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zd1a58c9e9ce3478b948a4748e1a21721" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ATOM is currently the only active registrational Phase 3 trial in adjuvant uveal melanoma.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PRAME</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Brenetafusp (IMC-F106C) is the Company&#8217;s lead PRAME-A02 ImmTAC bispecific candidate.&#160; Brenetafusp is being evaluated in combination with nivolumab, in
        a Phase 3 registrational trial (PRISM-MEL-301) in patients with first-line advanced cutaneous melanoma and in a Phase 1/2 clinical trial, as monotherapy and in combination, across multiple tumor types, including ovarian, non-small cell lung
        (NSCLC), and endometrial carcinoma.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">PRISM-MEL-301 &#8211; First PRAME Phase 3 clinical trial with brenetafusp in first-line advanced or metastatic HLA-A*02:01 positive
        cutaneous melanoma</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="za039c7ccfe3149ecb36dbd9500bb5c5d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Ongoing randomization of patients in PRISM-MEL-301 in multiple countries.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z65ef9ea51b8d4840ad6d64cb88537897" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Trial is evaluating brenetafusp + nivolumab versus a control arm of either nivolumab or nivolumab + relatlimab.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Phase 1/2 clinical trial of brenetafusp (PRAME-A02) in multiple solid tumors</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb02a4571a4f9449294f4654cd7278e6d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Clinical data presented at ESMO 2024 from the Phase 1 trial in patients with heavily pre-treated platinum-resistant high grade serous ovarian cancer showed signals of activity in heavily
                pretreated, platinum resistant patients. Disease control rate was 58% in monotherapy patients and 69% for combination patients. Overall survival (OS) was still maturing (73% 6-months OS rate in the monotherapy cohort). ctDNA molecular
                response rate was 31% and 82%, respectively, in the monotherapy and combination cohorts, associated with longer progression free survival and OS. Brenetafusp is well tolerated as monotherapy and in combination with gemcitabine,
                nab-paclitaxel and pegylated doxorubicin.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z92fc68cb6a2442b3bd1c2874b7f40ea7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Data presented at ESMO 2024 showed peripheral blood T cell fitness signature is an important parameter of brenetafusp clinical activity in ovarian cancer and uveal melanoma.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z01618aaee02c4401829ceb22d6770f4d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The Company is currently evaluating brenetafusp in combination with non-platinum chemotherapies in platinum resistant ovarian cancer and with bevacizumab and with platinum chemotherapy in earlier
                lines of platinum sensitive ovarian cancer.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z527e58f629c848f2a81fdab006a75a34" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The Company continues signal detection for brenetafusp in metastatic non-small-cell lung cancer cohorts, including in combination with docetaxel and with osimertinib in earlier-line NSCLC. As a
                result, the Company will not release initial data in the fourth quarter of 2024.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">IMC-P115C (PRAME-A02 Half-Life Extended) &amp; IMC-T119C (PRAME-A24)</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb29a8321e38f4f2391f5cf598817bd19" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">On track for first patient to be treated in the Phase 1 trial with IMC-P115C in first half of 2025.</div>
          </td>
        </tr>

    </table>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional Oncology Candidates</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">IMC-R117C (first PIWIL1-A02 targeted immunotherapy) for colorectal and other gastrointestinal cancers</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The Company has leveraged its proprietary peptidomic database to validate a novel target, PIWIL1. PIWIL1 is a negative prognostic marker and is
        expressed across a range of tumors including colorectal, which is historically insensitive to immune checkpoints, as well as gastro-esophageal, and pancreatic cancer.</div>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zebb869e6812d4769b8c363ac54ca4700" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Remain on track to treat the first patient in the Phase 1/2 trial of IMC-R117C in the fourth quarter of 2024.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="za0d88e8a88eb46afb8cf6214cb303ca1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The Phase 1/2 trial will assess the safety and clinical activity of IMC-R117C, as a monotherapy and in combination with standards of care, in colorectal and other gastrointestinal cancers.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ImmTAV candidates for a functional cure in infectious diseases</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The Company&#8217;s bispecific TCR technology platform has potential to offer a new approach for the treatment of chronic infections and aims to eliminate
        evidence of remaining virus in circulation after the patient stops taking medication - known as a "functional cure". Two investigational candidates are in Phase 1 clinical trials for people living with human immunodeficiency virus (HIV) and people
        with chronic Hepatitis B infection (HBV).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Phase 1 trial of IMC-M113V (Gag-A02) for people living with HIV</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4fc90ee255e947fb88717ab710c11e3f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The objective of the clinical trial is to identify a safe and tolerable dose and evaluate whether IMC-M113V could lead to reduction in the viral reservoir and, after stopping antiretroviral
                therapies and IMC-M113V, delay or prevent HIV rebound.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z0793099edf6a456d9fef72e765d95470" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><strike>&#8226;</strike></td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">A biologically active dose in the multiple ascending dose (MAD) portion of the trial has been reached and the Company is enrolling more people living with HIV to characterize anti-viral activity
                and to explore higher doses with data expected in the first quarter of 2025.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Phase 1 trial of IMC-I109V (Envelope-A02) for people living with HBV</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="ze6eed226c2694eb3b5ad88471c2f99d6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Expect to complete the single ascending dose (SAD) portion of the trial in the fourth quarter of 2024.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Tissue-specific down modulation of the immune system for autoimmune diseases</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The Company is expanding its platform into autoimmune diseases with two new, first-in-class bispecific candidates recently entering its pipeline. The
        key differentiator of the Company&#8217;s ImmTAAI (Immune Modulating Monoclonal TCRs Against AutoImmune disease) platform is tissue-specific down modulation of the immune system whereby, when tethered to the tissue of interest, the new candidates
        suppress pathogenic T cells via PD1 receptor agonism.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">IMC-S118AI (pre-pro insulin A02 x PD1), intended for disease-modifying treatment in type 1 diabetes</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="ze1e0eaf064ba4fa3970f336acd07f84c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">IMC-S118AI recognizes a peptide from pre-proinsulin presented by HLA-A02 on beta cells, coupled with a PD1 agonist effector arm.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Undisclosed non-HLA restricted (universal) candidate for inflammatory dermatological diseases</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="ze1c8461a89b643368f6310bdb5fc3d41" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The candidate is an antigen presenting cell (APC) tethered ImmTAAI and is not HLA restricted (i.e. universal for all populations).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Corporate Updates</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In August, Chief Financial Officer (CFO) and Head of Strategy, Brian Di Donato, informed the Company of his plans to leave at the end of the year, to take the role of
        Chief Executive Officer at a private, early-stage biotech headquartered in San Diego, California. The Company is progressing in its search for a new CFO. Brian will remain as the Company&#8217;s CFO and Head of Strategy through the end of 2024, to ensure
        a smooth transition.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Results</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the third quarter ended September 30, 2024, the Company generated net product sales of $80.2 million compared to $62.6 million for the same period in 2023. This
        increase was due to revenue from KIMMTRAK, of which $57.3 million was in the United States, $21.0 million in Europe, and $1.9 million in international regions. The increase in net product sales was due primarily to increased volume in the United
        States and global country expansion, as the Company continued its commercialization efforts.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the third quarter ended September 30, 2024, research and development (R&amp;D) expenses were $52.8 million, compared to $43.2 million for the same period in 2023.
        This increase was primarily driven by expenses incurred for the tebentafusp programs, including the Phase 3 trials: TEBE-AM in previously treated advanced cutaneous melanoma and ATOM in adjuvant uveal melanoma.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the quarter ended September 30, 2024, SG&amp;A expenses were $35.5 million, compared to $35.5 million for the same period in 2023.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share was $0.17 for the quarter ended September 30, 2024, as compared to a basic and diluted earnings per share of $0.02 for the same
        period in 2023. Net income for the quarter ended September 30, 2024 was $8.7 million, as compared to $0.9 million for the same period in 2023.</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: left; font-family: 'Times New Roman';">Cash, cash equivalents, and marketable securities at September 30, 2024 were $901.3 million. The Company plans to use existing cash to repay its $50 million loan by the end of 2024 and
        also expects to pay approximately $40 million in sales-related rebate accruals in the fourth quarter of 2024.</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About ImmTAC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> molecules for cancer</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore&#8217;s proprietary T cell receptor (TCR) technology generates a novel class of bispecific biologics called ImmTAC (Immune mobilizing
      monoclonal TCRs Against Cancer) molecules that are designed to redirect the immune system to recognize and kill cancerous cells. ImmTAC molecules are soluble TCRs engineered to recognize intracellular cancer antigens with ultra-high affinity and
      selectively kill these cancer cells via an anti-CD3 immune-activating effector function. Based on the demonstrated mechanism of T cell infiltration into human tumors, the ImmTAC mechanism of action holds the potential to treat hematologic and solid
      tumors, regardless of mutational burden or immune infiltration, including immune &#8220;cold&#8221; low mutation rate tumors.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About ImmTAV<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> molecules and infectious diseases</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">ImmTAV (Immune mobilizing monoclonal TCRs Against Virus) molecules are novel bispecifics that are designed to enable the immune system to recognize
      and eliminate virally infected cells.</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore is advancing clinical candidates to achieve functional cure for patients with HIV and hepatitis B virus (HBV). The Company aims to
      achieve sustained control of HIV after patients stop anti-retroviral therapy (ART), without the risk of virological relapse or onward transmission. This is known as &#8216;functional cure&#8217;. For the treatment of HBV, the Company aims to achieve sustained
      loss of circulating viral antigens and markers of viral replication after stopping medication for people living with chronic HBV.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About ImmTAAI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> molecules and autoimmune diseases</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">ImmTAAI (Immune mobilizing monoclonal TCRs Against AutoImmune disease) molecules are novel bispecifics that are designed for tissue-specific down
      modulation of the immune system. When tethered to the tissue of interest, ImmTAAI candidates suppress pathogenic T cells via PD1 receptor agonism. The Company is currently advancing two candidates for autoimmune diseases, including type 1 diabetes
      and inflammatory dermatological diseases.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About PRISM-MEL-301 (NCT06112314) &#8211; Phase 3 trial with brenetafusp (IMC-F106C, PRAME-A02) in 1L advanced cutaneous melanoma</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Phase 3 registrational trial is randomizing HLA-A*02:01-positive patients with previously untreated advanced melanoma, to brenetafusp +
      nivolumab versus nivolumab or nivolumab + relatlimab, depending on the country where the patient is enrolled. The trial will initially randomize to three arms: two brenetafusp dose regimens (40 mcg and 160 mcg) and a control arm. One of the two
      brenetafusp dose regimens will be discontinued after an initial review of the first 60 patients randomized to the two experimental arms (90 patients randomized total). The primary endpoint of the trial is progression free survival (PFS) by blinded
      independent central review (BICR), with secondary endpoints of overall survival (OS) and overall response rate (ORR).</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About the IMC-F106C-101 Phase 1/2 trial</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">IMC-F106C-101 is a first-in-human, Phase 1/2 dose escalation trial in patients with multiple solid tumors, including non-small cell lung cancer
      (NSCLC), small-cell lung cancer (SCLC), endometrial, ovarian, cutaneous melanoma, and breast cancers. The Phase 1 dose escalation trial was designed to determine the maximum tolerated dose (MTD), as well as to evaluate the safety, preliminary
      anti-tumor activity and pharmacokinetics of IMC-F106C (brenetafusp), a bispecific protein built on Immunocore&#8217;s ImmTAC technology, and the Company&#8217;s first molecule to target the PRAME antigen. The Company is enrolling patients into three expansion
      arms in NSCLC, as well as ovarian and endometrial carcinomas. The IMC-F106C-101 trial is adaptive and includes the option for Phase 2 expansion, allowing for approximately 100 patients treated per tumor type in the Phase 1 and 2 expansion arms. Dose
      escalation continues in additional solid tumors as well as plans for combination arms with standards-of-care, including checkpoint inhibitors, chemotherapy, and tebentafusp.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About TEBE-AM &#8211; Phase 3 registrational trial with tebentafusp in previously treated advanced cutaneous melanoma</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The trial is randomizing patients with second-line or later advanced cutaneous melanoma who have progressed on an anti-PD1, received prior
      ipilimumab and, if applicable, received a BRAF kinase inhibitor. Patients are randomized to one of three arms, including tebentafusp &#8211; as monotherapy or in combination with an anti-PD1 &#8211; or a control arm. The primary endpoint is overall survival.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About the ATOM Phase 3 trial &#8211; Phase 3 registrational trial with tebentafusp in adjuvant uveal melanoma</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The EORTC-led Phase 3 clinical trial will include sites in 10 EU countries and the United States and will randomize HLA-A*02:01-positive patients
      with high-risk primary uveal melanoma after definitive treatment, by surgery or radiotherapy, and no evidence of metastatic disease on imaging. The trial is expected to enroll a total of 290 patients who will be randomized 1:1 to one of two arms:
      tebentafusp as monotherapy or observation. The primary endpoint of the trial is relapse-free survival (RFS), with secondary objectives of overall survival and safety and tolerability of tebentafusp. Exploratory objectives include comparison of
      health-related quality of life between the treatment arms and evaluation of the role of circulating tumor DNA (ctDNA) as a biomarker for the presence of residual disease.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Uveal Melanoma</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Uveal melanoma is a rare and aggressive form of melanoma affecting the eye. Although it is the most common primary intraocular malignancy in adults,
      the diagnosis is rare, and up to 50% of people with uveal melanoma will eventually develop metastatic disease. Unresectable or metastatic uveal melanoma typically has a poor prognosis and had no approved treatment until KIMMTRAK.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Cutaneous Melanoma</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Cutaneous melanoma (CM) is the most common form of melanoma. It is the most aggressive skin carcinoma and is associated with the vast majority of
      skin cancer-related mortality. The majority of patients with CM are diagnosed before metastasis but survival remains poor for the large proportion of patients with metastatic disease. Despite recent progress in advanced melanoma therapy, there is
      still an unmet need for new therapies that improve first-line response rates and duration of response as well as for patients who are refractory to first-line treatments.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About KIMMTRAK<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">KIMMTRAK is a novel bispecific protein comprised of a soluble T cell receptor fused to an anti-CD3 immune-effector function. KIMMTRAK specifically
      targets gp100, a lineage antigen expressed in melanocytes and melanoma. This is the first molecule developed using Immunocore&#8217;s ImmTAC technology platform, designed to redirect and activate T cells to recognize and kill tumor cells. KIMMTRAK has been
      approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">IMPORTANT SAFETY INFORMATION</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Cytokine Release Syndrome (CRS), which may be serious or
        life-threatening, occurred in patients receiving KIMMTRAK. Monitor for at least 16 hours following first three infusions and then as clinically indicated.</font><font style="font-size: 10pt; color: rgb(0, 0, 0);"> Manifestations of CRS may include
        fever, hypotension, hypoxia, chills, nausea, vomiting, rash, elevated transaminases, fatigue, and headache. CRS occurred in 89% of patients who received KIMMTRAK, with 0.8% being grade 3 or 4. Ensure immediate access to medications and
        resuscitative equipment to manage CRS. Ensure patients are euvolemic prior to initiating the infusions. Closely monitor patients for signs or symptoms of CRS following infusions of KIMMTRAK. Monitor fluid status, vital signs, and oxygenation level
        and provide appropriate therapy. Withhold or discontinue KIMMTRAK depending on persistence and severity of CRS.</font></div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Skin Reactions</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Skin reactions, including rash, pruritus, and cutaneous edema occurred in 91% of patients treated with KIMMTRAK. Monitor patients for skin
      reactions. If skin reactions occur, treat with antihistamine and topical or systemic steroids based on persistence and severity of symptoms. Withhold or permanently discontinue KIMMTRAK depending on the severity of skin reactions.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Elevated Liver Enzymes</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Elevations in liver enzymes occurred in 65% of patients treated with KIMMTRAK. Monitor alanine aminotransferase (ALT), aspartate aminotransferase
      (AST), and total blood bilirubin prior to the start of and during treatment with KIMMTRAK. Withhold KIMMTRAK according to severity.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Embryo-Fetal Toxicity</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">KIMMTRAK may cause fetal harm. Advise pregnant patients of potential risk to the fetus and patients of reproductive potential to use effective
      contraception during treatment with KIMMTRAK and 1 week after the last dose.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The most common adverse reactions (&#8805;30%) in patients who received KIMMTRAK were cytokine release syndrome, rash, pyrexia, pruritus, fatigue, nausea,
      chills, abdominal pain, edema, hypotension, dry skin, headache, and vomiting. The most common (&#8805;50%) laboratory abnormalities were decreased lymphocyte count, increased creatinine, increased glucose, increased AST, increased ALT, decreased
      hemoglobin, and decreased phosphate.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">For more information, please see full Summary of Product Characteristics (SmPC) or full U.S. Prescribing Information (including BOXED WARNING for
      CRS).</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About KIMMTRAKConnect</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore is committed to helping patients who need KIMMTRAK obtain access via our KIMMTRAKConnect program. The program provides services with
      dedicated nurse case managers who provide personalized support, including educational resources, financial assistance, and site of care coordination. To learn more, visit KIMMTRAKConnect.com or call 844-775-2273.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">About Immunocore</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX &#8211;
      Immune mobilizing monoclonal TCRs Against X disease &#8211; designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is
      developing a deep pipeline in multiple therapeutic areas, including nine active clinical and pre-clinical programs&#8203; in oncology, infectious diseases, and autoimmune diseases. The Company&#8217;s most advanced oncology TCR therapeutic, KIMMTRAK, has been
      approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Forward Looking Statements</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the Private Securities Litigation
      Reform Act of 1995. Words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;anticipate&#8221; and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements.
      All statements, other than statements of historical facts, included in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding the commercial performance of KIMMTRAK, including the
      Company&#8217;s plans to expand distribution of KIMMTRAK to additional jurisdictions once regulatory approval is received; the potential benefits and advantages that KIMMTRAK will provide for patients, including its potential for expansion into other
      indications such as cutaneous and adjuvant uveal melanoma; expectations regarding the design, progress, timing, enrollment, randomization, scope, expansion, funding, and results of the Company&#8217;s existing and planned clinical trials; the timing and
      sufficiency of clinical trial outcomes to support potential approval of any of the Company&#8217;s product candidates or those of, or combined with, its collaboration partners; the Company&#8217;s goals to develop and commercialize product candidates based on
      its KIMMTRAK platform alone or with collaboration partners; the potential regulatory approval, expected clinical benefits and availability of the Company&#8217;s product candidates; and the use of the Company&#8217;s cash, cash equivalents and marketable
      securities, including the Company&#8217;s intent to repay in full its outstanding loan under the Pharmakon debt facility and make payments of sales-related rebate accruals. Any forward-looking statements are based on management&#8217;s current expectations and
      beliefs of future events and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially and adversely from those set forth in or implied by such forward-looking statements, many of which are
      beyond the Company&#8217;s control. These risks and uncertainties include, but are not limited to, the impact of worsening macroeconomic conditions on the Company&#8217;s business, financial position, strategy and anticipated milestones, including Immunocore&#8217;s
      ability to conduct ongoing and planned clinical trials; Immunocore&#8217;s ability to obtain a clinical supply of current or future product candidates or commercial supply of KIMMTRAK or any future approved products; Immunocore&#8217;s ability to obtain and
      maintain regulatory approval of its product candidates, including KIMMTRAK; Immunocore&#8217;s ability and plans in continuing to establish and expand a commercial infrastructure and to successfully launch, market and sell KIMMTRAK and any future approved
      products; Immunocore&#8217;s ability to successfully expand the approved indications for KIMMTRAK or obtain marketing approval for KIMMTRAK in additional geographies in the future; the delay of any current or planned clinical trials, whether due to patient
      enrollment delays or otherwise; Immunocore&#8217;s ability to successfully demonstrate the safety and efficacy of its product candidates and gain approval of its product candidates on a timely basis, if at all; competition with respect to market
      opportunities; unexpected safety or efficacy data observed during preclinical studies or clinical trials; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials or future regulatory approval;
      Immunocore&#8217;s need for and ability to obtain additional funding, on favorable terms or at all, including as a result of worsening macroeconomic conditions, including changes in inflation and interest rates and unfavorable general market conditions,
      and the impacts thereon of the war in Ukraine, the conflict in the Middle East, and global geopolitical tension; Immunocore&#8217;s ability to obtain, maintain and enforce intellectual property protection for KIMMTRAK or any of its product candidates it or
      its collaborators are developing; and the success of Immunocore&#8217;s current and future collaborations, partnerships or licensing arrangements. These and other risks and uncertainties are described in greater detail in the section titled "Risk Factors"
      in Immunocore&#8217;s filings with the Securities and Exchange Commission, including Immunocore&#8217;s most recent Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on February 28, 2024, as well as
      discussions of potential risks, uncertainties, and other important factors in the Company&#8217;s subsequent filings with the SEC. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this
      information, except as required by law.</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Contact Information</div>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Immunocore</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">S&#233;bastien Desprez, Head of Communications</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">T:<font style="font-family: 'Times New Roman';">&#160;</font>+44 (0) 7458030732</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">E: <u><font style="font-family: 'Times New Roman';">sebastien.desprez@immunocore.com</font></u></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Follow on Twitter: @Immunocore</div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investor Relations</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Clayton Robertson, Head of Investor Relations</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">T: +1 (215) 384-4781</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">E: <u><font style="font-family: 'Times New Roman';">ir@immunocore.com</font></u></div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Immunocore Holdings plc</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Condensed Consolidated Statement of Operations</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Comparison of the Quarters and Year to Date Ended <font style="font-family: 'Times New Roman';">September 30, 2024</font> and <font style="font-family: 'Times New Roman';">2023</font></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands, except share and per share data)</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(Unaudited)</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z8cf4520bd3ff4459823127dc4307d061" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Quarter Ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Year to Date</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">30, 2024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">30, 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">30, 2024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">30, 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Product revenue, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">80,248</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">62,629</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">225,937</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">171,142</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Collaboration revenue</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">2,221</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">213</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">8,124</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total revenue</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">80,248</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">64,850</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">226,150</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">179,266</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Cost of product revenue</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(448</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(276</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(2,401</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(837</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Research and development expense</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(52,770</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(43,249</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(161,301</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(117,980</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Selling, general, &amp; administrative expense</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(35,532</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(35,469</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(113,457</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(103,046</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Loss from operations</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(8,502</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(14,144</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(51,009</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(42,597</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Interest income</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">5,960</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">5,142</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">20,445</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">12,546</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Interest expense</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(4,290</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(1,321</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(11,806</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(3,845</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Foreign currency gain (loss)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">3,963</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">11,246</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1,049</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(647</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other income (expense), net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">8,962</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(192</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">13,205</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(706</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net income (loss) before income taxes</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">6,093</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">731</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(28,116</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(35,249</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Income tax benefit (expense)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">2,643</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">175</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">800</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(308</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net income (loss)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">8,736</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">906</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(27,316</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(35,557</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Basic net income (loss) per share</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">0.17</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">0.02</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(0.55</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(0.73</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-style: italic;">Basic weighted average number of shares</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">50,021,939</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">49,134,037</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">49,971,267</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">48,671,732</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Diluted net income (loss) per share</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">0.17</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">0.02</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(0.55</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">(0.73</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">)</font></font></div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 52%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-style: italic;">Diluted weighted average number of shares</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">52,808,434</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">54,158,967</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">49,971,267</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">48,671,732</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 52%;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"> <img src="image00002.jpg"></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Immunocore Holdings plc</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Condensed Consolidated Balance Sheets</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands)</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(Unaudited)</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z6f943e66dd35421da92f9f799506a30e" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September 30, 2024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31, 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">ASSETS</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Current assets</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">537,767</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">442,626</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Marketable securities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">363,515</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accounts receivable, net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">63,659</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">52,093</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Prepaid expenses and other current assets</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">36,446</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">29,600</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Inventory, net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">4,518</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">4,501</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total current assets</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">1,005,905</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">528,820</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Property and equipment, net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">9,160</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">9,215</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Operating lease right of use assets, net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">39,672</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">33,520</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred tax assets, net</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">12,663</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">10,973</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other non-current assets</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">17,238</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">14,473</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total assets</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">1,084,638</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">597,001</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Liabilities and shareholders&#8217; equity</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Current liabilities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accounts payable</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">19,721</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">17,798</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accrued expenses and other current liabilities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">197,224</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">119,835</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Operating lease liabilities, current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1,097</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1,388</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Interest-bearing loans and borrowings, current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">48,207</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total current liabilities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">266,249</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">139,021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accrued expenses, non-current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">3,006</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">978</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred revenue, non-current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">5,797</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">5,515</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Operating lease liabilities, non-current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">41,271</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">34,633</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Interest-bearing loans and borrowings, non-current</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">390,488</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">48,011</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">706,811</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">228,158</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Shareholders' equity</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Ordinary shares</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">135</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">134</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred shares</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Additional paid-in capital</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1,180,854</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">1,149,643</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accumulated deficit</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(771,990</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(744,674</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accumulated other comprehensive loss</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(31,173</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(36,261</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total shareholders' equity</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">377,827</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">368,843</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total liabilities and shareholders' equity</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">1,084,638</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">597,001</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50%;">
                <div>&#160;<img src="image00004.jpg"></div>
              </td>
              <td style="width: 50%; text-align: right; vertical-align: bottom;">
                <div>&#160;
                  <div style="color: rgb(0, 59, 127); font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 8pt; font-style: normal; font-variant: normal; text-transform: none;">Page&#160;11 of 12 </font></div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"> <img src="image00002.jpg"></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Immunocore Holdings plc</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Summary Condensed Consolidated Statements of Cash Flows</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">For the Year to Date Period Ended <font style="font-family: 'Times New Roman';">September 30,</font></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(In thousands)</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(Unaudited)</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z9721e8d4b98f47a1a999dda0151533b0" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September 30, 2024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">September 30, 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Cash and cash equivalents at beginning of period</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">442,626</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">402,472</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net cash provided by operating activities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">40,012</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">20,673</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net cash used in investing activities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(351,589</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(4,608</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net cash provided by financing activities</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">395,392</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">28,092</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net foreign exchange difference on cash held</div>
          </td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">11,326</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="font-size: 10pt; color: rgb(0, 0, 0); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="font-family: 'Times New Roman';">(2,491</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; color: rgb(0, 0, 0); text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; color: rgb(0, 0, 0); width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Cash and cash equivalents at end of period</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">537,767</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">$</font></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div><font style="font-size: 10pt; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-weight: bold;">444,138</font></font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="font-size: 10pt; color: rgb(0, 0, 0);">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div>&#160;<img src="image00004.jpg"></div>
            </td>
            <td style="width: 50%; text-align: right; vertical-align: bottom;">
              <div>&#160;
                <div style="color: rgb(0, 59, 127); font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 8pt; font-style: normal; font-variant: normal; text-transform: none;">Page&#160;12 of 12 </font></div>
              </div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> <br>
      </div>
    </div>
    <div style="font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>imcr-20241106.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<xs:schema targetNamespace="http://immunocore.com./20241106" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:imcr="http://immunocore.com./20241106" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="imcr-20241106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="imcr-20241106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://immunocore.com./role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>imcr-20241106_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>imcr-20241106_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://immunocore.com./role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="imcr-20241106.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://immunocore.com./role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  8 .<# 2(  A$! Q$!_\0
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M'WB/8-N['?&,UE2;5*\)<NK_ "1I-+VGOJ^AN0?!;0H95D76/$A*]FU#(_\
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;N_P__P! CQ+_ ."__P"RHHHK?ZA1,OK50__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  Z 6<# 2(  A$! Q$!_\0
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M=@DOSJRX7'[L_+R03GBJY(=PYI=CKK._M[RU-Q"SB(9R98VBQCOA@#CWK/\
M^$IT;[''=?;5,$A8*P1C]TX8D8R .Y/%9MEH6H3:/J%I/.UDES,'BB$GG^4G
M&5RPY#$'CWQ6</#VM0:'<66VVN6GEGPZ/Y#1AFRO('*^JTE&/<'*78ZE-?TQ
M[[[&MY&9^1C!VY R1NQMSCG&<TQ?$FDM!+,MXNR,J#\C9.[[NT8RV<'&,YQ7
M*R>%M8GN)(Y9(U$CR,UPDI\O:T90 0XP&Y'S9SP?6G6_AS5H;FWNXX8T^QM$
MRVK73.L[*&4MN(^3AA@8/2GR0[BYI=CJ9/$>DQ0V\KWJ>7<#=&0K'C.,G ^4
M9XR<<UK*<C(Y!Z&N!/AK5HH[QHXK:234X)89D,I"VQ>1FRO'S !O;D5W-K%Y
M%K%%G=Y:!,^N!BHFHK9E1;>Y+1114%A1110 4444 %%%% '(^)?$UUI6I31J
MD206\<<F'B9FN S8;:0<+CWS5RQU74CKT-I>Q6PBN8I)D2+)>%5("ESG!W9]
M!R#5W4M&T^^O(I[Q29>%VB0JLFT[@&4'#8//--TW1[.TOI[VWGNGDD)$GF73
MR+GTP20,?I6EXVV(M*YS=GXQNA=,]TL<UJ)Y8G2"W<-%M;:GS$[6+'C%:S^+
M(':2""UO/M@$H\MHQ\A0#);G&.1TK3.BV)TV6P\H_9I7,C+N.=Q;=D'J#GD5
M!;>'M-LWDF1)-[+('DDF9B0^-Q))]AS0Y0?024EU*6G>(S>^%+C4K=1))!;-
M(9,?NVD"DD#UP1@U7A\3W&GS10:PBW$D\,4L)LXR"Q<D;"I/J.N:V+/0M-@L
M9[:UBVVMS%Y;HLAVLN,9'/4COUJ.U\-:= $PDLCJR,))9F=QLSM&XG.!D\=*
M+PU"TM"O%XIME:Y2Y619(G("A.3^\V;>O+9(S]:LZ/XCL=7NG@M"^X+O5F P
MZYQD8)[CO@TDNA:5+>1,\8-Q#.UVH$IR'8\DC/(SC@\5&NA:9IKBXB=K4!P<
MF<A0,GY!DX )/04O<L-<QF7/BFZM]:UJTDAA,5O$IM" <O(< JW/JR]/6J5O
MXRO6L+.:6&%I_+WW$4:D<^47P"3ZBNGN/#VFW-W'=2PEIDG^TJP<CY\ <\\C
M@<=.*A3PYH\#H/) 8Y"JTA^;Y2I&">>":KFA;85I]R"#Q;:F*)KBVNHLJAE8
MH"L+.,J&.>XQTSU&:LZ7K]MJ2S?9H9XW6 7"B9 N]#G##!]01S4:^&=)$L:$
M2LRJOR-<,=X484L,_-CH">E7[32+*U(,$9&+<6OWR?W8)('ZGFI?)T&N;J<I
MH/C*ZG6V>]C%TES&NS[+;NA64DXC^<X;@$YR.E7;[QC"^GW;Z?!<>=#$96:6
M,!8P&*_-S['I6W)HED^FVUCY;K!;%6A*2%60CH0P.<]:@@\,Z7!;3P1P-Y<Z
M;) 9&)89)ZD^I-4Y0>MA6G:UR[H^H1ZI9)<P!S"WW)","0?WE]O2KM9UCI%O
M83*UH9(H@& A#G8">X7H*T:S=KZ%J]M0HHHI#"BBB@ HHHH **** "BBB@#'
MUSQ#9Z*7%X)25B\X!%SN&[! ]QG/TJE<^,M,MQ<%A.PAQRJ9W_-M.WGG!!S[
M"M'6=.TV]FLY=2V;X&8P[I-O+#!&,\\=JJQ^%-(2&SB%NVRT\SRLR,?O@AL\
M\]3UK1<EM2'S7T(9O&.FQ-(&$YV2+&"$R&RQ7(YY (.33KSQ1:P6]O=#<;5S
M*"=F68)U*\T\>$]'6*TC^SMMMHFABS*V=K=<\\GD\GGFG_\ "+Z7]DBMC#(8
M(D\N-#,Q"C !QSW H_=B]\KGQA9)YGG6]["(R5<O&,*P3>!P>ZC(I4\761?:
M]O>1 ,JLSQ@!=R[E)Y[C_P"O5VZ\/Z==1S)-"665_,<;R,MLV?\ H)Q3GT'3
MWW;H2=QC8_.>3&,+^E%X#]\J2>*;)#;JL5S))<)&\2(@);?NVCK_ +)ID?B[
M3Y C(EP8B%\V3RQM@+' #\\'/IFI+'PYI,,L5Q;J[LA4QL9V<#;NV@9/0;CQ
M2_\ ",:3$RR>2R*F&9?-8(^#D%QG#8/3-'N"]\8OBFU>%)%M;TB9@MO^Z'^D
M9SC8<X[$\XJ/_A,=.*RL$N?+AC625]@ CW' 4Y/WL\8I]OX>T::(K;,[JK H
M8[EB82,XV$'Y.IZ8ZU87P[I4-I<0_9P()HU24,YY"\@YSU'7-'N#]\;'XELY
M-/%TB3L3-]F$"J"YD_NCG'8G.<5&WBBS24))!=IC:)6>+ @9ONJ_/4^V>HJ1
M/#FFFW"+Y[*6$@?[0Y8-DD.&SG=SUZXH_P"$8TL2(_E2':!N!F8B0CH7&?F(
MSU-'N![Q5B\8V+[2;:]1"J2;VC& CMM5^O3/'K[5THK&CT+2Y;<+''NB,*0
MB0D%$;<HSGUK46:(0F02)Y2]7W# Q[U,K=!QOU):*:9$&W+*-W"Y/7Z4Q+F!
MW=4FC9D^\ X)7Z^E242T5'Y\6Q'\Q-CG"MN&&^E*TT:LRM(@*KN(+ 8'K]*
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M"JN(_NMDDC(P,9.1SD<4.3VY027<I>$]2O)@\&H^<78EH6DCVDH ,YX'<G'
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5.ZMBBCF=K!RK<****DH**** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45169587636304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  06,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Immunocore Holdings plc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001671927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">92 Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Milton Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Abingdon<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oxfordshire<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">OX14 4RY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1235 438600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMCR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME>:7,6? YCK \Y52]JWAOB24'X)&_P%02P,$%     @ UCIF69^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ UCIF60=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #6.F99U"MS"^X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #6.F99F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -8Z
M9EGRB&%5J00  !02   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #6.F99GZ ;\+$"  #B#   #0
M        @ 'L#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -8Z9EF7BKL<
MP    !,"   +              "  <@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( -8Z9ED<.&7J/P$  #P"   /              "  ;$0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #6.F99)!Z;HJT   #X 0  &@
M    @ $=$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #6.F9999!YDAD!  #/ P  $P              @ $"$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !,%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20038108_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://immunocore.com./role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20038108_8k.htm">ef20038108_8k.htm</File>
    <File>imcr-20241106.xsd</File>
    <File>imcr-20241106_lab.xml</File>
    <File>imcr-20241106_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20038108_8k.htm": {
   "nsprefix": "imcr",
   "nsuri": "http://immunocore.com./20241106",
   "dts": {
    "inline": {
     "local": [
      "ef20038108_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "imcr-20241106.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "imcr-20241106_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imcr-20241106_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://immunocore.com./role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20241106to20241106",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038108_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20241106to20241106",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038108_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://immunocore.com./role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-24-045343-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-045343-xbrl.zip
M4$L#!!0    ( -8Z9EG6PL8EAA,  'N!   1    968R,# S.#$P.%\X:RYH
M=&WM76USVSB2_CZ_ J>IFSB[IL3W%]GQEB,[B3:)[9(]-7/W90L$0 D3BM2
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M;(23.?2IH4OC .VW)$%5MP)H49&'J8!V2VA Q9,6IGF>#J&"T37*TIA3%,:
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ML/7U,KN&9@5!8#ZNFE[.8*Q3RD&@\6NMR#"WU\MG@Y.:H\/1* 99 !)74MU
MW K79U#X0H!Q1V&8##Y3"/L$^@NBOHSR(BH%CX37\>[M2P2-G4XZ'/),[FQ
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M])!IZ4T@?)3T92$:GLAD:1MIA17.X:'ZZCG.VJ] L$4@.$_!$P'32_I?8>*
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M]+WO/A2V!";;JWT9[T^4QRC.YZQI]C>TL.R2PB?KQJLYOYKSF^I,Y NPY\Z
MLPABF^HVT5-UFZC8EDFO[M<=5KV%;,6ZD<EM/TW[#&[.^Z7Z/=Z6_(%O]8/?
M^3 ^^']02P,$%     @ UCIF68AGNHK[1@  0,L# !4   !E9C(P,#,X,3 X
M7V5X.3DM,2YH=&WM?5ESVTB6[OM$S'_(JUI&N@VI 1#<;)=C9-GN\FV[[)94
MW3./22 IH@P"; "4S/KU]YR3F5BX:#,E E)V=)0EB 02F><[^_)JDD^CU__Y
M'XR]F@@>T$_P<Q[FD7C]ZJ_R7W7Q_QP>LH^A+^),!"Q/7K"S^70:YNQ]&//8
M#WDD/T?_>YOX\ZF(<^:G@N?P^7D6QA?L39KP( V#"\&^G'X>AY%@KG<T/'*.
MNF[7K7S_))DMTO!BDC-G..RR0^;:KE?]^N&A7/5?U;)?C9)@P487?A(EZ2][
M/XSI?WLLRQ>1^&5OG,3YX9A/PVCQ@OW7>3@5&?M-7+'39,KC_WK)Z.]9^*=X
MP1Q[EK]DN?B6'_(HO(A?L$B,X0K=^07[P:;_O=R3S\<OUAY2N<G>:U@?7E0;
MG+(XR28\@(^J'_88/>*7/=C57*3%<B<"W_T%\V;?5A[,1MS_>I$F\S@X7/Y3
M==7REB_9E*<787R(+_&"\7F>%)=2^1!Y;92D@8![Q4DL],L%X:5>4?7.]#WX
MS.K+7ZEUCY(H6-W4O=?OODW"$9#,$(Y<;<T-._AJE&KZ4Y__*ZRJ6-[KFT[@
MIN^KOVUX4[V':I_3B]&^;3'\_X%ZO;O0U.H6[;W^,)W.X\1/4L%2,4O2/&/Y
M)$P#]N\Y3^'9;*S1!7_/YA'\G<<!FZ7)91C  SD;(;1$EK'Y+ "HE>]7?ZV5
MU:Q[I_I^W7Y_:C36.>ILNO\]]XR>_(*%.3S6AT7^_<.G3^>GQW]_E<UG>EF7
M(LU#GT=Z:;3,/)F]9!%LSZ%&E%-[1C;E400OL/?ZYQ^<OO?RU5_ACJ_9?BY&
M\&9\/,]FA_!S?,!BD<,!7(IX#BM.QNS'@7WD,GB/*$QB%L:L\P_B419S!S\Q
M@.=5/F$)+$K]H;.3<WG ,_@RX9E@'9:G0)L9[H _SWDLDGG&IB+B,=R-)?%%
M@GQ__\OIA[-/AY_>?3SLV Y1\/F[-^\.CS_!>O"WVMWP9CSX8W[) =GS2P%7
MBCON'Y]__G0 XD<+BRP'G+ 4;I),PS_Q8?!M3Q[&D]MS8 'X%+U?#ANE BB3
M")4!^CF^_"SB>1C/IX?PZ1"V!S8QN>2PL7!$P$J )&?P ;A/]K(XH Q> ;8Y
M$+GP<T714[@Q?!U0Q7X[._EXHG?\"HB>99-PG,.GPAP/C!Z=BDC JG#M/A!!
MG%S![9G@:12*]!!16#R8SMQ/IB-@;OBX[*F=E.(&^/8Q[&_&9K#M(/*!S>^_
M^W)V0"S$/G+ZN LSN(P:E685##ZA/F"[M]V9NV["'_,L#\>+N[_PWNO]59E[
MS??7G]CG_WG_^?3MV:\?3M]9[%U\$2%%_,RGP*]//O]V]NOG7S^?_/W=;Q;[
M(N+X2/WE;\<?SG]]=WKVYO?3OUGL4W!DL=_/E%R'^_;8;\!QIR/8:MS\ TVP
MK^9KM(S-*ZX)Y5]!3,L#C'RV_QO/ O[O%^S#IY/3 [;_\P\#U[5?EA^G"R!B
MDA2DN&#J[R=XQ/%"_?&@4$3FL&B.!# 5*4IXH"(.JNTH3 "%DQCV[6(AZ2->
ML!G 1(@4P8I;%8@HO)2_YL#\LG&23@%*EX*%M)II$LR)#UP CH/01Q6APC53
M'J"PC!;P<=0E!$OF.3P*/@1W*G%Z%8(8DUS# K2/B3L N(,P0ZQ+(*,"24\5
MQ74+GA7P!?PY!D75!_(.X6ZKNLQ8[51=YQ%Q -\X$[-<GF8'J(;@5%%]@E75
MYVB9[E\7%'!+X-2ALQD\TB*X.W(40?Q+,.0$\"9SPKW4_.#M$M@+X!-Y"GQ9
M[X:%VM57.NBKA"V HY "XL/-@<OC82AM _=2:T;R7-3]]+;"MV9)%A*5H#X3
MQGCBEB;:.Z%ZG2Z;\3!@;_@D_(.S_P?$Q2.+U;'A]%]F[&02BC%[]TV PH!+
M^3P>@U69*E@<L?HF@7*1P Y\U5(JA ]S6F=*"C#I"I=(5O"!9)Z"2 0C$> R
M$R1RZ+'P=D3)57$)7TQBGT!F$0W^^N&?; S$B@*I:LSZ<UA&H9BL 8%%NXT+
M606"?&X>9ME<'(*J<B%0?,/)7Z1\JNA_,4-1'H1\!'_,%+P1SK@XD+[Z7D?J
MI&IDWCSQH,Y/DV)Q[LN*\3\Z+ (%@TB:A;"=*5!#S$8+-@&R@@\$8JHV%H_G
M=] UD"N 1J(VZ6^X2?&"?H9OB6_ *)$Q*.X%L.+^1!Z X\"SX&PG@NRKC!ZZ
M9<H_Y=%LPLZ3=,07UQ#^2<'O;Z!\\<VG-^8CX,VT!3,0##$I7, T1L3\"\##
ME2D*K#KK+O3F? +,YF)"M]'*ME+!%6WG$YYKHH<-@MT$.I=Z"<J@"&@3&'.:
M1!$Y=D*IVBV0,?<D JKW1C6]<F.\(^BE<2QO6%?:2064QZ)8U5I*OR=U/Q S
M7TL'YR3&_J'X+8FL7^$#$7XH8_O <*,YJA/(A_-#T G#)#C8+')V)ZK6OEUA
M=C_X@Y?5Z7.@K(H616@"8X,8:3#W<ZO @864QF>DTQ#KZ R ?.<QD*+B&D"@
M;"2 T2B&0)]RG<JG+J)D1+H14"KJ%<2E?_UX?'C\?VWW!=BO6HJ6,J*.NGF,
MAIJ?\U$D4!>L6%++YNST]T\'1R6*E50G70U629!"$R[@0%<H]9$QH&T&]$-Z
M@<!G K.$JP0R_5)'K+)G+!/$]U(AV%>QT%P8[L6SFMKPHEA (-EIIFW!WS]9
M=194OGOU@[!J]^-?E$2&FZSQ"9!FLMZZ/]H&%%9XA@]2)OME[\WIE_=?0+]^
M V_]]1C^4WA;?2"E%*D\GQ2NK#R9:8I45^#/>3(M'E];Y+I'%+>?P97#$5XZ
MY.,<?:P\NN*+K'*33=YA=0>Y G(',QM=PE=AD$]P*?9/VG-[J*[9+YGV=;EW
M]!Y7]V'O]75[^HC@7\N)/FT"U$,04/DA"6A?1%$VXZAP_K)G[]'O,QX$^O<P
M^&7O3\\?>WP\=!S;[7N#[IASW^^/Q]VQT^OU1MS;TS3S]NS+^X]AEI_CO>\?
MKZA1Q"V#%_)_E:@+O&'ZNOH[7@GTFO0C!N5);=I.O:EY<,O;K7AOT7%[3]6S
M]_)6#Y9AC[4/WJP(UYY6?\(:<KO.QU"P?+3$E!AC&8_09$!V7G<P(]/\T76[
M1\/B4FDZ(UO'#\1H[TSAP9-LHPEMH>F-FAV(KVB!O\VD4U%Z3C%<ETD/-ZKK
M>->.^]/2=[3+:OG]&0HM$A*@UZ12KY<Z3K;$V3?0!UQ(UU F7$9PW N'8V\T
M$+W <X>^[?&1SX-1S^URQQY[GL^'(X/#9X[#OTE=2!N99S7+\HI7S5(-CT!;
MIB/Z!;!8:DWHS9N#I;H R@=DI]*VP0^CTH4@"^;J(F LQ^@XFE-;Q,=6Q%?'
MZXT"U^^,Q[[G"3'B0[\3##RG-^J+[K@S,+!I"6PJBMCV,(._(.V3@VT4)0E0
M-U [6@(@*<@4H(!2CIXSB@TAD&9%](I+=\:[>9K,!(_96>*' B"#(NV3(,\T
M^ZQ\<]**_B0$2:C]=V>?/DOO/H)N'*93\HRBB^&<2)F-PYQ\PH!HN30T"&/T
M<R<I!L-6I18(,PXFFO20^O!2M ".\BY4JRJD-<;74G&)_C\T$'5VRW5FS#;!
MO%F;K>J\]U!M=Z/'HZVX9CM7K<;&Z/7N6/1\FWM#UQUX'=0FQAT[&'F^TQMT
M^YYK&.-S9HRG-8]FZ<Q1VD4J+H BI/@'?E%/>MC7&1$6NYJ$/JHDZ"TL'#<\
MG69%-*/@1Z#N4Y"'SQ96C4M5HNO2*34#0R!-HO#/^92/+!6!CW.X5/<52<=O
MME:Y+QS!==>M>CW@QEG.)CP:D_U@N[V=J?WND+O=4<\;![;G=4?!B-N!UW>#
M\4",_"X?&Y@^9Y@BN>O@QTKF$<JD-6Y+=!MSM&RG/%V@>3U+0LRL&5,PBV-*
MS#R]#"]Y]"BZ?(.B!+>0\\=U?^\^:%2)/X]X>M \"1\X=M 3WK@SMGW/[0X&
M';<+DK[+1P%<'QG6T1;6\5 >@]-ULH_BG35>8L$!4ERZ9NI\3B]X'&;RNVA9
MG()1Q%,0]Y04J?T!R%=.9++>_KO/I^<G!Q38PC!IROVO90Q5B]YDGH*,KV1Z
MH(W4-*]"X/#NP!^*H2\Z7G\P&GH#[O6]@7"XZ_1=QT"K)=!Z$*E,$ (B]^=I
M"A"()'*2&'X@6_P&_7ESTO!VM= M2Z:'#]M_.3W^].[Q8_9O*KE6^Q\^G1R^
M=^S>R0&><+XIG$]+/3RV74R?.3\^8:,0 P^8\X59B$%(:7X__^#T[)>L^H 0
M8_KH"1*@@,W)B;#.!HK#RR22]D\8EV?-"U):HC!EF=6RUP_(!U2+]Y/A(S.<
M;XI\(Y7J[.V_NJ6W28D,4#(K%IW^1N4]X"-^FF3PL7F4AV",L7P^54EDF<7*
M#!.5\FUA0<\AU3E(]U@TCR_*-]^GS.X#:0X*E&M"OK,/,BG<6DQ^9XIGO>Y
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M<PQ2[3!/N#G9 R9%8 N>&I/6^W#^30,F Z9GFFIKP&3 U$HP-3+]]:FFH1G
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M/DF <17WUWMNV_7DJU>T$0RW#_;5A[/X9<_>H]_5V=#O$C3TXUVH<,V>:2;
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MW-L7"]Q++!)A1949U?8^K M[/8ESXJ%U ':0^7>#I#/NC^.8\9;7?\Z3#$]
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MYN"<?>)O;:V;DNHMI[/_ 5!+ P04    " #6.F99N'UI+]P%  #W/@  %0
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MGK# P3NCCN)A_K!DTRXYMI=V$5:6\$9LD'\^WT;DB_RS]L?_ 5!+ 0(4 Q0
M   ( -8Z9EG6PL8EAA,  'N!   1              "  0    !E9C(P,#,X
M,3 X7SAK+FAT;5!+ 0(4 Q0    ( -8Z9EF(9[J*^T8  $#+ P 5
M      "  ;43  !E9C(P,#,X,3 X7V5X.3DM,2YH=&U02P$"% ,4    " #6
M.F99^MVYV%(#  "X#P  $0              @ 'C6@  :6UC<BTR,#(T,3$P
M-BYX<V102P$"% ,4    " #6.F995TBO&7L(   P5@  %0
M@ %D7@  :6UC<BTR,#(T,3$P-E]L86(N>&UL4$L! A0#%     @ UCIF6;A]
M:2_<!0  ]SX  !4              ( !$F<  &EM8W(M,C R-#$Q,#9?<')E
:+GAM;%!+!08     !0 % $<!   A;0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20038108_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="imcr-20241106.xsd" xlink:type="simple"/>
    <context id="c20241106to20241106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671927</identifier>
        </entity>
        <period>
            <startDate>2024-11-06</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20241106to20241106"
      id="Fact_1cd53765c7d64384a42eb28bf0b95bc9">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20241106to20241106"
      id="Fact_adeda0fcc3224eabbbeb25f24d8e78ea">0001671927</dei:EntityCentralIndexKey>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20241106to20241106"
      id="Fact_9fe653d954de4755b60b19a3917feed9">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType
      contextRef="c20241106to20241106"
      id="Fact_ca45266cdc824e089d0d7fe7075c51ed">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20241106to20241106"
      id="Fact_d75e030939ee44c4a90b7a750089a473">2024-11-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20241106to20241106"
      id="Fact_0ff371c6b84d4464886e7a127f5580c2">Immunocore Holdings plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20241106to20241106"
      id="Fact_810a65b3a7d344f0a3119c25a252c800">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20241106to20241106"
      id="Fact_5085908fe79442c1a669570a1a7f940a">001-39992</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20241106to20241106"
      id="Fact_b65bc2914d3c4a9bb069e4af9c3e9f15">92 Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20241106to20241106"
      id="Fact_bb5eaec8f04e4a4cb48ea8de2b3ccad4">Milton Park</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="c20241106to20241106"
      id="Fact_4b98402cd79e40c6b7006c60f084dbac">Abingdon</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="c20241106to20241106"
      id="Fact_0f79bba9963d4a26849ef7da8f49812f">Oxfordshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20241106to20241106"
      id="Fact_e1097750da464755a29bd136ba8bbe89">GB</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20241106to20241106"
      id="Fact_716d770ab6974ace8abf23e996a4f637">OX14 4RY</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20241106to20241106"
      id="Fact_212ec1f8f2dc427492d391baa1ee86a4">44</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20241106to20241106"
      id="Fact_a9b83eff89ac4a928db39f2aa853bc53">1235 438600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20241106to20241106"
      id="Fact_8b0d0eaeaf8f43729fd1f893856137eb">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20241106to20241106"
      id="Fact_fbe3715ec5df4b39966f53f803957aa0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20241106to20241106"
      id="Fact_518ccbbaf16d43d7a33bbe81eeb1b3b0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20241106to20241106"
      id="Fact_06a931cfab8c4e1bbc41452f85c4eaa1">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20241106to20241106"
      id="Fact_7bcfd8b4b4854d32b6864532d70881c3">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20241106to20241106"
      id="Fact_21a85a61990a4d2fa6eb8308d1aee54c">IMCR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20241106to20241106"
      id="Fact_57738f115e1e466fb007e1f768097b35">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20241106to20241106"
      id="Fact_817885c40eeb40e0a6a33045bf337539">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
